Skip to main content

Search

Reset all filters
44 Result(s)
Sort by

Partnering for innovation and growth

Partnering for innovation and growth

In this interview Dr Frerich de Vries talks about why partnerships are one of the key areas of interest for Boehringer Ingelheim and more. Learn more.
Our Partnering Culture

Our Partnering Culture

We embrace the power of partnerships and alliances to find even more breakthrough therapies that change lives. Find out more about our partnering culture.
Co-creation with Communities

Co-creation with Communities

Making More Health has launched co-creation projects in Asia, Africa, Europe and other localities around the world with top social entrepreneurs.
History of Cats

History of Cats

Since the beginning of human civilisation, cats have been companions to people. Click here to learn more about the history of cats with humans.
From Idea to Drug

From Idea to Drug

Development of a new drug starts with the hunt for effective compounds and finishes with the approval of the drug. Click here to learn more.
Collaboration to fight NCDs

Collaboration to fight NCDs

70 percent of global deaths are attributable to NCDs and severely impacting on people in low- and middle-income countries. Help is desperately needed.
Trust Through Transparency

Trust Through Transparency

Trust is a precious thing, and building trust takes hard work—especially in the healthcare sector. Click here to learn more about how we build trust.
Transboundary and emerging diseases

Transboundary and emerging diseases

We fight TEDs through cutting-edge technologies. Click here to find out how our colleagues in Global Innovation and VPH prepare for outbreaks.
More Health Overview

More Health Overview

Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations. Learn more.
Innovation Needs Transparency

Innovation Needs Transparency

At Boehringer Ingelheim, we prioritise the establishment and maintenance of public trust. Transparency is therefore a key pillar of our corporate culture.
Interview: Excellence in stem cell treatments

Interview: Excellence in stem cell treatments

Acquisition of GST reflects the enormous potential of biotechnology research to provide breakthrough therapies for major diseases. Learn more.
Resizing our Carbon Footprint

Resizing our Carbon Footprint

The ecological balance of the world is at a tipping point. Thus, we step up the initiative “Carbon Footprint”. Click here to find out more information.
Our Commitment

Our Commitment

We want to create value in areas of unmet medical need and engage with communities and society to improve lives – for humans and animals. Find out more.
Stroke, Don’t Stay at Home

Stroke, Don’t Stay at Home

During COVID-19, there was a decrease in stroke hospital admissions. Learn why it is crucial that patients can still access urgent care at this time.
BI Access to Healthcare Strategy_Availability

BI Access to Healthcare Strategy_Availability

Through our Access to Healthcare Strategy, we want to ensure that our compounds are readily and responsibly available. Learn more about our work here.
COVID-19 Making More Health support program

COVID-19 Making More Health support program

Find out what our communities, local partners and social entrepreneurs in the Making More Health network do. Click here to find out and learn more.